Thymosin β4: A multi-functional regenerative peptide. Basic properties and clinical applications

Expert Opinion on Biological Therapy

Volumn 12, Issue 1, 2012, Pages 37-51

  Goldstein, Allan L ^a   Hannappel, Ewald ^b   Sosne, Gabriel ^c   Kleinman, Hynda K ^d  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

Apoptosis; Inflammation; Migration; Regeneration; Scar formation; Stem cells; Thymosin 4; Tissue repair

Indexed keywords

DOXYCYCLINE; RGN 352; THYMOSIN BETA4; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ALZHEIMER DISEASE; BURN; CELL DIFFERENTIATION; CELL MIGRATION; CHEMICAL INJURY; CORNEA INJURY; DECUBITUS; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DRUG TOLERABILITY; DRY EYE; EMBRYONIC STEM CELL; EPIDERMOLYSIS BULLOSA; FIBROSIS; HEART INFARCTION; HUMAN; MULTIPLE SCLEROSIS; MYOFIBROBLAST; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); RADIATION INJURY; REVIEW; SCAR FORMATION; SKIN INJURY; SPINAL CORD INJURY; STEM CELL; STROKE; TISSUE REGENERATION; TISSUE REPAIR; TRAUMATIC BRAIN INJURY; WOUND HEALING;

ANIMALS; APOPTOSIS; BLOOD PLATELETS; CELL MOVEMENT; CLINICAL TRIALS AS TOPIC; FIBROSIS; HUMANS; INFLAMMATION; MODELS, BIOLOGICAL; MOLECULAR WEIGHT; MYOFIBROBLASTS; PEPTIDES; PHYLOGENY; REGENERATION; SKIN; STEM CELLS; THYMOSIN; WOUND HEALING;

EID: 84055193007     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.2012.634793     Document Type: Review

References (97)

1. Low TL, Hu SK, Goldstein AL. Complete amino acid sequence of bovine thymosin beta4: a thymic hormone that induces terminal deoxynucleotidyl transferase activity in thymocyte populations. Proc Natl Acad Sci USA 1981;78:1162-6 (Pubitemid 11102180)
2. Hu SK, Low TL, Goldstein AL. Modulation of terminal deoxynucleotidyl transferase activity by thymosin. Mol Cell Biochem 1981;41:49-58 (Pubitemid 12142400)
3. Low TL, Wang SS, Goldstein AL. Solid-phase synthesis of thymosin beta 4: chemical and biological characterization of the synthetic peptide. Biochemistry 1983;22:733-40 (Pubitemid 13134037)
4. Goldstein AL, Hannappel E, Kleinman HK. Thymosin beta4: Actin-sequestering protein moonlights to repair injured tissues. Trends Mol Med 2005;11:421-9 (Pubitemid 41254045)
5. Hannappel E. Thymosin beta4 and its posttranslational modifications. Ann NY Acad Sci 2010;1194:27-35
6. Butler GS, Overall CM. Proteomic identification of multitasking proteins in unexpected locations complicates drug targeting. Nat Rev Drug Discov 2009;8:935-48
7. Safer D, Elzinga M, Nachmias VT. Thymosin beta4 and Fx, an actin-sequestering peptide, are indistinguishable. J Biol Chem 1991;266:4029-32 (Pubitemid 21909312)
8. Huff T, Muller CS, Hannappel E. Thymosin beta4 is not always the main beta-thymosin in mammalian platelets. Ann NY Acad Sci 2007;1112:451-7 (Pubitemid 47598667)
9. Safer D, Sosnick TR, Elzinga M. Thymosin beta4 binds actin in an extended conformation and contacts both the barbed and pointed ends. Biochemistry 1997;36:5806-16 (Pubitemid 27214932)
10. Zarbock J, Oschkinat H, Hannappel E, et al. Solution conformation of thymosin beta4: a nuclear magnetic resonance and simulated annealing study. Biochemistry 1990;29:7814-21 (Pubitemid 20281227)
11. Stoll R, Voelter W, Holak TA. Conformation of thymosin beta9 in water/fluoroalcohol solution determined by NMR spectroscopy. Biopolymers 1997;41:623-34
12. Haritos AA, Yialouris PP, Heimer EP, et al. Evidence for the monomeric nature of thymosins. FEBS Lett 1989;244:287-90 (Pubitemid 19067144)
13. Huff T, Hannappel E. Oxidation and reduction of thymosin beta4 and its influence on the interaction with G-actin studied by reverse-phase HPLC and postcolumn derivatization with fluorescamine. Anal Chim Acta 1997;352:249-55 (Pubitemid 27522828)
14. Freeman KW, Bowman BR, Zetter BR. Regenerative protein thymosin beta 4 is a novel regulator of purinergic signaling. FASEB J 2011;25:907-15
15. Frohm M, Gunne H, Bergman AC, et al. Biochemical and antibacterial analysis of human wound and blister fluid. Eur J Biochem 1996;237:86-92 (Pubitemid 26110276)
16. Yun YR, Won JE, Jeon E, et al. Fibroblast growth factors: biology, function, and application for tissue engineering. J Tissue Eng 2010;2010:218142
17. Itoh N, Ornitz DM. Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease. J Biochem 2011;149:121-30
18. Bao L, Loda M, Janmey PA, et al. Thymosin beta15: a novel regulator of tumor cell motility upregulated in metastatic prostate cancer. Nat Med 1996;2:1322-8 (Pubitemid 26401734)
19. Smart N, Riseboro CA, Melville AA, et al. Thymosin beta4 induces adult cardiac progenitor mobilization and neovascularization. Nature 2007;445:177-82 (Pubitemid 46095717)
20. Morris DC, Chopp M, Zhang L, et al. Thymosin Tbeta4 improves functional neurological outcome in a rat model of embolic stroke. Neuroscience 2010;169:674-82
21. Morris DC, Chopp M, Zhang ZG. Thymosin beta4: a candidate for treatment of stroke. Ann NY Acad Sci 2010;1194:112-17
22. Philp D, Nguyen M, Scheremeta B, et al. Thymosin beta4 increases hair growth by activation of hair follicle stem cells. FASEB J 2004;18:385-7
23. Badamchian M, Fagarasan MO, Danner RL, et al. Thymosin beta4 reduces lethality and down-regulates inflammatory mediators in endotoxin-induced septic shock. Int Immunopharmacol 2003;3:1225-33 (Pubitemid 36830863)
24. Cavasin MA. Therapeutic potential of thymosin beta4 and its derivative N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP) in cardiac healing after infarction. Am J Cardiovasc Drugs 2006;6:305-11 (Pubitemid 44749340)
25. Sosne G, Szliter EA, Barrett R, et al. Thymosin beta 4 promotes corneal wound healing and decreases inflammation in vivo following alkali injury. Exp Eye Res 2002;74:293-9 (Pubitemid 34948404)
26. Sosne G, Qiu P, Christopherson PL, Wheater MK. Thymosin beta 4 suppression of corneal NFkappaB: a potential anti-inflammatory pathway. Exp Eye Res 2007;84:663-9 (Pubitemid 46420439)
27. Sosne G, Christopherson PL, Barrett RP, Fridman R. Thymosin-beta4 modulates corneal matrix metalloproteinase levels and polymorphonuclear cell infiltration after alkali injury. Invest Ophthalmol Vis Sci 2005;46:2388-95 (Pubitemid 43119484)
28. Young JD, Lawrence AJ, Mac Lean AG, et al. Thymosin beta 4 sulfoxide is an anti-inflammatory agent generated by monocytes in the presence of glucocorticoids. Nat Med 1999;5:1424-7
29. Bock-Marquette I, Saxena A, White MD, et al. Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature 2004;432:466-72 (Pubitemid 39576522)
30. Ehrlich HP, Sprague WH. Thymosin beta4 enhances repair by organizing connective tissue and preventing the Thymosin b4: a multi-functional regenerative peptide. Basic properties and clinical applications 48 Expert Opin. Biol. Ther. (2012) 12(1) appearance of myofibroblasts. Ann NY Acad Sci 2010;1194:118-24
31. Huang LC, Jean D, Proske RJ, et al. Ocular surface expression and in vitro activity of antimicrobial peptides. Curr Eye Res 2007;32:595-609 (Pubitemid 47400679)
32. Ho JH, Tseng KC, Ma WH, et al. Thymosin beta-4 upregulates anti-oxidative enzymes and protects corneal epithelial cells against oxidative damage. Br J Ophthalmol 2008;92:992-7 (Pubitemid 351969686)
33. Ho JH, Chuang CH, Ho CY, et al. Internalization is essential for the antiapoptotic effects of exogenous thymosin beta-4 on human corneal epithelial cells. Invest Ophthalmol Vis Sci 2007;48:27-33 (Pubitemid 47251382)
34. Sosne G, Siddiqi A, Kurpakus-Wheater M. Thymosin-beta4 inhibits corneal epithelial cell apoptosis after ethanol exposure in vitro. Invest Ophthalmol Vis Sci 2004;45:1095-100 (Pubitemid 38869013)
35. Malinda KM, Goldstein AL, Kleinman HK. Thymosin beta4 stimulates directionalmigration of human umbilical vein endothelial cells. FASEB J 1997;11:474-81 (Pubitemid 27259989)
36. 36, Qiu P, Kurpakus-Wheater M, Sosne G. Matrix metalloproteinase activity is necessary for thymosin beta 4 promotion of epithelial cell migration. J Cell Physiol 2007;212:165-73 (Pubitemid 46867598)
37. Roy P, Raifur Z, Jones D, et al. Local photorelease of caged thymosin beta4 in locomoting keratocytes causes cell turning. J Cell Biol 2001;153:1035-48
38. Sosne G, Hafeez S, Greenberry AL II, Kurpakus-Wheater M. Thymosin beta4 promotes human conjunctival epithelial cell migration. Curr Eye Res 2002;24:268-73 (Pubitemid 35155742)
39. Sosne G, Xu L, Rpach L, et al. Thymosin beta 4 stimulates laminin-5 production independent of TGF-beta. Exp Cell Res 2004;293:175-83 (Pubitemid 38064424)
40. Sosne G, Qiu P, Goldstein AL, Wheater M. Biological activities of thymosin beta4 defined by active sites in short peptide sequences. FASEB J 2010;24:2144-51
41. Hinkel R, El-Aouni C, Olson T, et al. Thymosin beta4 is an essential paracrine factor of embryonic endothelial progenitor cell-mediated cardioprotection. Circulation 2008;117:2232-40
42. Shah SP, Youngquist ST, Mcclung CD, et al. Markers of progenitor cell recruitment and differentiation rise early during ischemia and continue during resuscitation in a porcine acute ischemia model. J Interferon Cytokine Res 2011;31:509-13
43. Smart N, Dube KN, Riley PR. Identification of thymosin beta4 as an effector of Hand1-mediated vascular development. Nat Commun 2010;1:1-10
44. Smart N, Bollini S, Dube KN, et al. De novo cardiomyocytes from within the activated adult heart after injury. Nature 2011;474:640-4
45. Xiong Y, Mahmood A, Meng Y, et al. Treatment of traumatic brain injury with thymosin beta4 in rats. J Neurosurg 2011;114:102-15
46. Grant DS, Kinsella JL, Kibbey MC, et al. Matrigel induces thymosin beta4 gene in differentiating endothelial cells. J Cell Sci 1995;108:3685-94 (Pubitemid 26003202)
47. Han T, Liu Y, Liu H, et al. Serum thymosin beta4 levels in patients with hepatitis B virus-related liver failure. World J Gastroenterol 2010;16:625-30
48. Sopko N, Qin Y, Finan A, et al. Significance of thymosin beta4 and implication of PINCH-1-ILK-alpha- Parvin (PIP) complex in human dilated cardiomyopathy. PLoS One 2011;6(1):e20184
49. Lv S, Cheng G, Xu Y, et al. Relationship between serum thymosin beta4 levels and coronary collateral development. Coron Artery Dis 2011;22:401-4
50. De Santis M, Inzitari R, Bosello SL, et al. beta-thymosins ad interstitial lung disease: study of a scleroderma cohort with a one-year follow-up. Respir Res 2011;12(1):22
51. Vartiainen N, Pyykonen I, Hokfelt T, Koistinaho J. Induction of thymosin beta4 mRNA following focal brain ischemia. Neuroreport 1996;7:1613-16 (Pubitemid 26332334)
52. Cha HJ, Philp D, Lee SH, et al. Overexpression of thymosin beta4 promotes abnormal tooth development and stimulations of hair growth. Int J Dev Biol 2010;54:135-40
53. Crockford D, Turjman N, Allan C, Angel J. Thymosin beta4:structure, function, and biological properties suporting current and future clinical applications. Ann NY Acad Sci 2010;1194:179-89
54. Ruff D, Crockford D, Girardi G, Zhang Y. A randomized, placebo-controlled, single and multiple dose study of intravenous thymosin beta4 in healthy volunteers. Ann NY Acad Sci 2010;1194:223-9
55. Malinda KM, Sidhu GS, Mani H, et al. Thymosin beta4 accelerates wound healing. J Invest Dermatol 1999;113:364-8 (Pubitemid 29449075)
56. Philp D, Badmamchiam M, Scheremeta B, et al. Thymosin beta4 and a synthetic peptde containing its actin-binding domain promote dermal wound reapri in db/db diabetic mice and in aged mice. Wound Repair Regen 2003;11:19-24 (Pubitemid 36268605)
57. Li X, Zheng L, Peng F, et al. Recombinant thymosin beta 4 can promote full thickness cutaneous wound healing. Protein Expr Purif 2007;56:229-36 (Pubitemid 350011045)
58. Guarnera G, Derosa A, Camerini R. The effectof thymosin treatment on venous stasis ulcers. Ann NY Acad Sci 2010;1194:207-12
59. Ehrlich HP, Kelley SF. Documentation of hypertrophic scar development by laser Goldstein, Hannappel, Sosne & Kleinman Expert Opin. Biol. Ther. (2012) 12(1) 49 doppler blood flow monitoring. Plast Reconstr Surg 1992;90:993-8
60. Sosne G, Albeiruti AR, Hollis B, et al. Thymosin beta4inhibits benzalkonium choloride-mediated apoptosis in corneal and conjunctival epithelial cells in vitro. Exp Eye Res 2006;83:502-7 (Pubitemid 44183802)
61. Gillitzer R, Goebeler M. Chemokines in cutaneous wound healing. J Leukoc Biol 2001;69:513-21 (Pubitemid 32294835)
62. Wilson SE, Netto M, Ambrosio R Jr. Corneal cells: chatty in development, homeostasis, wound healing, and disease. Am J Ophthalmol 2003;136:530-6 (Pubitemid 37101252)
63. Agrawal VB, Tsai RJ. Corneal epithelial wound healing. Indian J Ophthalmol 2003;51:5-15 (Pubitemid 36402148)
64. Stramer BM, Fini ME. Uncoupling keratocyte loss of corneal crystalline from markers of fibrotic repair. Invest Ophthalmol Vis Sci 2004;45:4010-15 (Pubitemid 39411155)
65. Wakefield D, Lloyd A. The role of cytokines in the pathogenesis of inflammatory eye disease. Cytokine 1992;4:1-5
66. Cubitt CL, Tang Q, Montiero CA, et al. IL-8 gene expression in culture of human corneal epithelial cells and keratocytes. Invest Ophthalmol Vis Res 1993;34:3199-206 (Pubitemid 23309060)
67. Cubitt CL, Lausch RN, Oakes JE. Differences in interleukin-6 gene expression between cultured human corneal epithelial cells and keratocytes. Invest Ophthalmol Vis Sci 1995;36:330-6
68. Sosne G, Chan CC, Thai K, et al. Thymosin beta 4 promotes corneal wound healing and modulates inflammatory mediators in vivo. Exp Eye Res 2001;72:605-8 (Pubitemid 32977230)
69. Qui P, Wheater MK, Sosne G. Thymosin beta 4 inhibits TNF-alpha-induced NF-kappaB activation, IL-8 expression, and the sensitizing effects by its partners PINCH-1 and ILK. FASEB J 2011;25:1815-26
70. Philp D, Scheremeta B, Sibliss K, et al. Thymosin beta4 promotes matrix metalloproteinase expression during wound repair. J Cell Physiol 2006;208:195-200 (Pubitemid 43849005)
71. Sosne G, Qui P, Kurpakas-Wheater M, Matthew H. Thymosin beta4 and corneal wound healing: visions of the future. Ann NY Acad Sci 2010;1194:190-8
72. Dunn SP, Heideman DG, Chow CY, et al. Treatment of chronic nonhealing neurotrophic corneal epithelial defects with thymosin beta 4. Arch Ophthalmol 2010;128:636-8
73. Srivastava S, Srivarava D, Olson EN, et al. Thymosin beta4 and cardiac repair. Ann NY Acad Sci 2010;1194:87-96
74. Rossdeutsch A, Smart N, Riley PR. Thymosin beta4 and Ac-SDKP: tools to mend a broken heart. J Mol Med 2008;86:29-35
75. Kraehenbuehl TP, Ferreira LS, Hayward AM, et al. Human embryonic stem cell-derived microvascular grafts for cardiac tissue preservation after myocardial infarction. Biomaterials 2011;32:1102-9
76. Zhou B, Honor LB, Ma Q, et al. Thymosin beta 4 treatment after myocardial infarction does not reprogram epicardial cells into cardiomyocytes. J Mol Cell Cardiol 2011;published online 26 August 2011; doi:10.1016/j.yjmcc.2011.08.020
77. Bollini S, Cheung KK, Riegler J, et al. Amniotic fluid stem cells are cardioprotective following acute myocardial infarction. Stem Cells Dev 2011;20:1-10
78. Doyle B, Sorajja P, Hynes B, et al. Progenitor cell theyrapy in a porcine acute myocardial infarction model induces cardiac hypertrophy, mediated by paracrine secretion of cardiotrophic factors including TGFbeta1. Stem Cells Dev 2008;17:941-51
79. Bock-Marquette I, Srivasatava S, Pipes GC, et al. Thymosin beta4 mediated PKC activation is essential to initiate the embryonic coronary developmental program and epicardial progenitor cll activation in adult mice in vivo. J Mol Cell Cardiol 2009;46:728-38
80. Giradi M, Sherling MA, Filler RB, et al. Anti-inflammatory effects in the skin of thymosin beta4 splice-variants. Immunology 2003;109:1-7 (Pubitemid 36577968)
81. Lin CX, Rhaleb NE, Yang XP, et al. Prevention of aortic fibrosis by N-acetyl-seryl-aspartyl-lysyl-proline in angiogenesis II-induced hypertension. Am J Physiol Heart Circ Physiol 2008;295:H1253-61
82. Peng H, Carretero OA, Brigstock DR, et al. Ac-SDKP reverses cardiac fibrosis in rats with renal renovascular hypertension. Hypertension 2003;42:1164-70 (Pubitemid 37549072)
83. Wang D, Carretero OA, Yang XY, et al. N-acetyl-seryl-aspartyl-lysyl- proline stimulates angiogenesis in vitro and in vivo. Am J Physiol Heart Circ Physiol 2004;287:H2099-105 (Pubitemid 39430749)
84. Zhang J, Zhang ZG, Morris D, et al. Neurological functional recovery after thymosin beta 4 treatment in mice with experimental auto encephalomyelitis. Neuroscience 2009;164:1887-93
85. Yang H, Cheng X, Yao Q, et al. The promotive effects of thymosin beta4 on neuronal survival and neurite outgrowth by upregulating L1 expression. Neurochem Res 2008;33:2269-80
86. Magharious M, D'Onofrio PM, Hollander A, et al. Quantitative iTRAQ analysis of retinal ganglion cell degeneration after optic nerve crush. J Proteome Res 2011;10:3344-62
87. Paulussen M, Arckens L. Striking neuronal thymosin beta 4 expression in the deep layers of the mouse superior colliculus after monocular deprivation. Brain Struct Func published online 31 May 2011; doi: 10.1007/s00429-011-0330-0
88. Popoli P, Pepponi R, Martire A, et al. Neuroprotective effects of thymosin beta4 in experimental models of excitotoxicity. Ann NY Acad Sci 2007;1112:219-24 (Pubitemid 47598671)
89. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000;132:365-86
90. Tang MC, Su Y. Thymosin beta4 knockdown disrupts mitochondrial functions of SW480 human colon cancer cells. Cancer Sci 2011;102:1665-72
91. Erickson-Viitanen S, Ruggieri S, Natalini P, Horecker BL. Distribution of thymosin beta4 in vertebrate classes. Arch Biochem Biophys 1983;221(2):570-6 (Pubitemid 13135516)
92. Hannappel E, Davoust S, Horecker BL. Thymosins beta8 and beta9: two new peptides isolated from calf thymus homologous to thymosin beta4. Proc Natl Acad Sci USA 1982;79:1708-11 (Pubitemid 12088496)
93. Hannappel E, Wartenberg F, Bustelo XR. Isolation and characterization of thymosin beta9Met from pork spleen. Arch Biochem Biophys 1989;273:396-402 (Pubitemid 19221994)
94. Erickson-Viitanen S, Ruggieri S, Natalini P, Horecker BL. Thymosin beta10, a new analog of thymosin beta4 in mammalian tissues. Arch Biochem Biophys 1983;225:407-13
95. Banyard J, Hutchinson LM, Zetter BR. Thymosin beta-NB is the human isoform of rat thymosin beta15. Ann NY Acad Sci 2007;1112:286-96 (Pubitemid 47598663)
96. Banyard J, Barrows C, Zetter BR. Differential regulation of human thymosin beta 15 isoforms by transforming growth factor beta 1. Genes Chromosomes Cancer 2009;48:502-9
97. Church DM, Goodstadt L, Hillier LW, et al. Lineage-specific biology revealed by a finished genome assembly of the mouse. PLoS Biol 2009;7(5):e1000112